What is Epishine?
Headquartered in Linköping, Sweden, Epishine specializes in the design and manufacturing of thin, flexible, and recyclable organic solar cells. Unlike traditional silicon-based photovoltaics, Epishine's technology is optimized for indoor ambient light, effectively converting light into electricity to power small electronics and wireless sensors. This innovation addresses the critical pain point of battery dependency in the Internet of Things (IoT) ecosystem, offering a sustainable alternative that reduces electronic waste and maintenance costs. By leveraging a scalable printing process, the firm achieves industry-leading efficiency, enabling seamless integration into a wide array of consumer and industrial hardware.
How much funding has Epishine raised?
Epishine has raised a total of $12M across 2 funding rounds:
Other Financing Round
$5.5M
Share Placement
$6.5M
Other Financing Round (2023): $5.5M, investors not publicly disclosed
Share Placement (2024): $6.5M led by Pareto Securities
Key Investors in Epishine
Pareto Securities
Pareto Securities is an independent full-service investment bank providing comprehensive corporate finance, project financing, and asset broking services to support high-growth industrial ventures.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Epishine?
With this major enterprise-level funding, Epishine is poised to transition from its current development phase into a broader commercial scaling stage. The strategic roadmap likely involves expanding manufacturing capacity to meet the rising demand for energy-autonomous sensors and smart home devices. Furthermore, the company is expected to deepen its research into material science to further enhance the efficiency of its light cells. As the industry shifts toward more sustainable power solutions, Epishine's ability to provide a reliable, low-cost energy source will be pivotal in defining the next generation of connected, self-sustaining technology.
See full Epishine company page